Fig 2.

Bayesian network analysis results for 5-year overall survival (A up), failure-free survival (A below), distant metastasis-free survival (B up), and locoregional recurrence-free survival (B below). Treatments in the rows were compared with those in the columns. Highlighting numbers, odds ratios (ORs) with significant differences. IC+CCRT, induction chemotherapy followed by concurrent chemoradiotherapy; CCRT+AC, concurrent chemoradiotherapy followed by adjuvant chemotherapy; CCRT, concurrent chemoradiotherapy.